
|Articles|October 1, 2004
Implant shows success in treating posterior uveitis
Durham, NC-Results of a 9-month randomized, dose-masked, multicenter clinical trial of a fluocinolone acetonide sustained drug delivery system to treat posterior uveitis resulted in significant gains for the eyes that received implants when compared with fellow eyes that did not receive implants, said Glenn J. Jaffe, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Development of maculopathy associated with systemic medications
2
Evolving glaucoma therapy: A new era of interventional strategies
3
STAAR postpones Alcon merger vote, Broadwood calls for removal of board members
4
Proactive strategies and sustained delivery advance glaucoma care
5

















































.png)


